Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect
Cancers · 11.02.2023 · 15 (4) · 1169
DOI: 10.3390/cancers15041169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.02.2023. Verfasst von Hongyang Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic-Biliary-Pancreatic Institute, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Science and Technique Innovation Project of Lanzhou University Second Hospital, the Doctoral Supervisors Research Fund of Lanzhou University Second Hospital, Gansu Provincial Science Foundation for Young Scholars of China.
Abstract (Originalsprache)
The lymphatic system is a channel for fluid transport and cell migration, but it has always been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has long been recognized as a major molecular driver of lymphangiogenesis. However, many studies have shown that the neural network of lymphatic signaling is complex. Lymphatic vessels have been found to play an essential role in the immune regulation of tumor metastasis and cardiac repair. This review describes the effects of lipid metabolism, extracellular vesicles, and flow shear forces on lymphangiogenesis. Moreover, the pro-tumor immune tolerance function of lymphatic vessels is discussed, and the tasks of meningeal lymphatic vessels and cardiac lymphatic vessels in diseases are further discussed. Finally, the value of conversion therapy targeting the lymphatic system is introduced from the perspective of immunotherapy and pro-lymphatic biomaterials for lymphangiogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatic-Biliary-Pancreatic Institute, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China.
- Key Laboratory of the Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China.
ORCID-Profile: Hongyang Deng, Fahong Wu
Förderung
- the Science and Technique Innovation Project of Lanzhou University Second Hospital
- the Doctoral Supervisors Research Fund of Lanzhou University Second Hospital
- Gansu Provincial Science Foundation for Young Scholars of China
- Cuiying Technology Innovation Project of Lanzhou University Second Hospital
- Doctoral Students Training Research Fund of Lanzhou University Second Hospital
Zitieren
APA
Deng, H., Zhang, J., Wu, F., Wei, F., Han, W., Xu, X., & Zhang, Y. (2023). Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect. Cancers, 15(4), 1169. https://doi.org/10.3390/cancers15041169
Vancouver
Deng H, Zhang J, Wu F, Wei F, Han W, Xu X, et al. Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect. Cancers. 2023;15(4):1169. doi:10.3390/cancers15041169
BibTeX
@article{Deng2023,
author = {Deng, Hongyang and Zhang, Jiaxing and Wu, Fahong and Wei, Fengxian and Han, Wei and Xu, Xiaodong and Zhang, Youcheng},
title = {Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect},
journal = {Cancers},
year = {2023},
volume = {15},
number = {4},
pages = {1169},
doi = {10.3390/cancers15041169}
}
EUVIMED